Action Point Financial Planning’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-330
Closed -$32.7K – 1450
2026
Q2
$32.7K Buy
+330
New +$29.7K ﹤0.01% 964

Other funds holding IHE

Action Point Financial Planning's IHE Position: Q3 2026 in Review

Action Point Financial Planning sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2026, closing a stake of 330 shares — an estimated $32.7K sold.

Action Point Financial Planning first reported a position in IHE in Q2 2026 and held it in 1 quarter. The position peaked at $32.7K in Q2 2026. 249 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Action Point Financial Planning reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 330 iShares US Pharmaceuticals ETF shares in Q3 2026, an estimated $32.7K.
  • Action Point Financial Planning first reported a position in iShares US Pharmaceuticals ETF in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's iShares US Pharmaceuticals ETF position peaked at $32.7K in Q2 2026.
  • 249 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.